Drug Shortage Report for ENGERIX-B

Last updated on 2019-04-18 History
Report ID 6511
Drug Identification Number 01919431
Brand name ENGERIX B INJ SUS 20MCG/ML
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-04-06
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-04-18
Company comments Inventory on allocation to support demand in private market. Supply available for public programs.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v44 2019-04-18 French Compare
v43 2019-04-18 English Compare
v42 2019-03-08 French Compare
v41 2019-03-08 English Compare
v40 2019-02-08 French Compare
v39 2019-02-08 English Compare
v38 2019-01-25 French Compare
v37 2019-01-25 English Compare
v36 2019-01-23 French Compare
v35 2019-01-23 English Compare
v34 2019-01-11 French Compare
v33 2019-01-11 English Compare
v32 2018-12-03 French Compare
v31 2018-12-03 English Compare
v30 2018-11-02 French Compare
v29 2018-11-02 English Compare
v28 2018-09-13 French Compare
v27 2018-09-13 English Compare
v26 2018-08-22 French Compare
v25 2018-08-22 English Compare

Showing 1 to 20 of 44